For those who remain needle-phobic, 2026 has seen an increase in the availability of semaglutide tablets
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown promise in preclinical models of neurodegeneration, with emerging evidence suggesting these effects may be driven by modulation of neuroinflammation
We offer a range of dermal fillers to treat almost any area of your face, including the cheeks, underneath the eyes, jawline, and around the mouth
Access is becoming easier, but the real challenge is ensuring long-term, sustainable outcomes
Reveal beautifully refreshed, luminous skin with every application
Our clinical team will review your medical history and decide if it is safe and suitable for you